1. Home
  2. FEMY vs WYY Comparison

FEMY vs WYY Comparison

Compare FEMY & WYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEMY
  • WYY
  • Stock Information
  • Founded
  • FEMY 2004
  • WYY 1991
  • Country
  • FEMY United States
  • WYY United States
  • Employees
  • FEMY N/A
  • WYY N/A
  • Industry
  • FEMY Medical/Dental Instruments
  • WYY EDP Services
  • Sector
  • FEMY Health Care
  • WYY Technology
  • Exchange
  • FEMY Nasdaq
  • WYY Nasdaq
  • Market Cap
  • FEMY 31.9M
  • WYY 33.6M
  • IPO Year
  • FEMY 2021
  • WYY 1998
  • Fundamental
  • Price
  • FEMY $0.95
  • WYY $3.10
  • Analyst Decision
  • FEMY Strong Buy
  • WYY Strong Buy
  • Analyst Count
  • FEMY 3
  • WYY 1
  • Target Price
  • FEMY $8.67
  • WYY $7.00
  • AVG Volume (30 Days)
  • FEMY 262.9K
  • WYY 74.8K
  • Earning Date
  • FEMY 08-07-2025
  • WYY 08-13-2025
  • Dividend Yield
  • FEMY N/A
  • WYY N/A
  • EPS Growth
  • FEMY N/A
  • WYY N/A
  • EPS
  • FEMY N/A
  • WYY N/A
  • Revenue
  • FEMY $1,699,232.00
  • WYY $142,582,209.00
  • Revenue This Year
  • FEMY $231.84
  • WYY $10.84
  • Revenue Next Year
  • FEMY $245.28
  • WYY $12.37
  • P/E Ratio
  • FEMY N/A
  • WYY N/A
  • Revenue Growth
  • FEMY 61.97
  • WYY 24.03
  • 52 Week Low
  • FEMY $0.69
  • WYY $2.19
  • 52 Week High
  • FEMY $1.80
  • WYY $6.25
  • Technical
  • Relative Strength Index (RSI)
  • FEMY 46.82
  • WYY 45.80
  • Support Level
  • FEMY $0.90
  • WYY $3.07
  • Resistance Level
  • FEMY $0.99
  • WYY $3.25
  • Average True Range (ATR)
  • FEMY 0.06
  • WYY 0.17
  • MACD
  • FEMY 0.00
  • WYY 0.00
  • Stochastic Oscillator
  • FEMY 18.18
  • WYY 31.37

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About WYY WidePoint Corporation

WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.

Share on Social Networks: